Large pharma drug licensing from China hits high at 28% in 2024 (www.pharmaceutical-technology.com)
from schizoidman@lemm.ee to world@lemmy.world on 02 Apr 02:55
https://lemm.ee/post/60149954

• The total deal value of US licensing of innovator drug candidates from Chinese biopharma companies has surged 280% since 2020.

• drug licensing agreements involving Chinese biopharma licensors has surged 66%, from $16.6 billion in 2023 to $41.5 billion in 2024

#world